All In MedTech

FDA Clearance Tracker · P130022-S036

Senza Spinal Cord Stimulation (SCS) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 6, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 6, 2021

Approved

Time to decision

199 days

Received Aug 19, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P130022-S036
Device name
Senza Spinal Cord Stimulation (SCS) System
Applicant location
Redwood City, CA
Received
Aug 19, 2020
Decided
Mar 6, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P130022

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for the Senza Bluetooth Trial system which consists of the following components: Bluetooth Trial Stimulator (TSM), Bluetooth Patient Remote (PTR), and Updated Clinician Programmer Software (PS). Accessory kits that support the Senza Bluetooth Trial system consist of the Trial Stimulator Pouch kit, Extra battery kit and the Magnet kit.

Source documents

Other decisions for Nevro Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.